The mammographic appearance of breast carcinomas of invasive ductal type: Relationship with clinicopathological parameters, biological features and prognosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 136, Issue 2, 2008, Pages 224-231

  Ildefonso, Concepcion ^a,b   Vazquez, Julio ^b,c   Guinea, Oscar ^c   Perez, Alejandro ^d   Fernandez, Amalia ^a   Corte, Maria D ^b,c   Junquera, Sara ^c   Gonzalez, Luis O ^b,c   Pravia, Paz ^c   Garcia Moran, Manuel ^e   Vizoso, Francisco J ^b,c  

^a Hospital del Oriente   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL DE JOVE   (Spain)

^d Hospital de Jarrio   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Breast cancer; Mammography; Microcalcifications; Prognosis

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN PS2;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CELL CYCLE S PHASE; DATA ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATHOLOGY; PLOIDY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RELAPSE;

EID: 38649137661     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.10.025     Document Type: Article

References (26)

1. Broberg A., Glas U., Gustafsson S.A., Hellstrom L., and Somell A. Relationship between mammographic pattern and estrogen receptor content in breast cancer. Breast Cancer Res Treat 3 (1983) 201-207
2. Paradiso A., Ventrella V., Farchi G., et al. Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer. Oncology 50 (1993) 104-109
3. Nielsen N.S., and Poulsen H.S. Relation between mammographic findings and hormonal receptor content in breast cancer. Am J Roentgenol 145 (1985) 501-504
4. Wilson T.E., Helvie M.A., Oberman H.A., and Joynt L.K. Pure and mixed mucinous carcinoma of the breast: pathologic basis for differences in mammographic appearance. Am J Roentgenol 165 (1995) 285-289
5. Bloom H.J., and Richardson W.W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11 (1957) 359-377
6. Corte M.D., Verez P., Rodriguez J.C., et al. Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance. Breast Cancer Res Treat 90 (2005) 33-40
7. Corte M.D., Tamargo F., Alvarez A., et al. Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical-pathological parameters and their prognostic significance. Breast Cancer Res Treat 96 (2006) 63-72
8. Corte M.D., Rodil J.A., Vazquez J., et al. Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). J Cancer Res Clin Oncol 131 (2005) 701-714
9. Rodriguez J., Vazquez J., Corte M.D., et al. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer. Int J Biol Markers 20 (2005) 103-111
10. Quintela I., Corte M.D., Allende M.T., et al. Expression and prognostic value of EGFR in invasive breast cancer. Oncol Rep 14 (2005) 1655-1663
11. Hedley D.W., Shankey T.V., and Wheeless L.L. DNA cytometry consensus conference. Cytometry 14 (1993) 471
12. Apsimon H.T., Stewart H.J., and Williams W.J. Recording the gross outlines of breast tumours. A pathological assessment of the accuracy of radiographs of breast cancers. Br J Cancer 22 (1968) 40-46
13. Wolfe J.N. Analysis of 462 breast carcinomas. Am J Roentgenol Radium Ther Nucl Med 121 (1974) 846-853
14. Bjurstam N.G. Radiography of the female breast and axilla. With special reference to diagnosis of mammary carcinoma. Acta Radiol Suppl 357 (1978) 1-131
15. Ciatto S., Morrone D., Catarzi S., and Bonardi R. Breast cancer: reliability of mammographic appearance as a predictor of hormone receptor status. Radiology 182 (1992) 805-808
16. Gajdos C., Tartter P.I., Bleiweiss I.J., et al. Mammographic appearance of non-palpable breast cancer reflects pathologic characteristics. Ann Surg 235 (2002) 246-251
17. Rio M.C., Bellocq J.P., Gairard B., et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 84 (1987) 9243-9247
18. Yamashita J., Ogawa M., and Sakai K. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer. Surgery 117 (1995) 601-608
19. Corte M.D., Tamargo F., Alvarez A., et al. Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical pathological parameters and their prognostic significance. Breast Cancer Res Treat 3 (2005) 1-10
20. von Rosen A., Wiege M., Tornberg B., et al. Relationship between certain radiographic and biologic characteristics in breast cancer. Acta Oncol 26 (1987) 89-93
21. McCann J., Britton P.D., Warren R.M., and Hunnam G. Radiological peer review of interval cancers in the East Anglian breast screening programme: what are we missing? East Anglian Breast Screening Programme. J Med Screen 8 (2001) 77-85
22. Liapis H., Crouch E.C., Grosso L.E., Kitazawa S., and Wick M.R. Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues. Am J Pathol 143 (1993) 1169-1178
23. Ferranti C., Coopmans de Yoldi G., Biganzoli E., et al. Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer. Br J Radiol 73 (2000) 698-705
24. Zunzunegui R.G., Chung M.A., Oruwari J., Golding D., Marchant D.J., and Cady B. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?. Arch Surg 138 (2003) 537-540
25. Heuser L.S., Spratt J.S., Kuhns J.G., Chang A.F., Polk Jr. H.C., and Buchanan J.B. The association of pathologic and mammographic characteristics of primary human breast cancers with "slow" and "fast" growth rates and with axillary lymph node metastases. Cancer 53 (1984) 96-98
26. Tabar L., Tony Chen H.H., Amy Yen M.F., et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer 101 (2004) 1745-1759